🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicole Pratt

University of South Australia

ORCID: 0000-0001-8730-8910

Also affiliated with Market Intelligence Strategy Centre (Australia), South Australian Health and Medical Research Institute, National Intelligence University, The University of Adelaide

Pharmacology, Toxicology and PharmaceuticsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.900Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

BMJ Medicine(2023)10.1136/bmjmed-2023-000651
Top 29%
0.692DataRank
Top 29%28 citations

Lovedeep Singh Dhingra, Arya Aminorroaya, Kelly Li, Jin Zhou, Faaizah Arshad +42 more

Papers

Driven by 17 papers — median percentile 35. Top paper: “Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM”.

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

BMJ Medicine(2023)10.1136/bmjmed-2023-000651
Top 29%
0.692DataRank
Top 29%28 citations

Lovedeep Singh Dhingra, Arya Aminorroaya, Kelly Li, Jin Zhou, Faaizah Arshad +42 more

Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis

medRxiv(2021)10.1101/2021.07.10.21258463
N/A
0.241DataRank · unranked
4 citations

Lana Yin Hui Lai, Anna Ostropolets, Faaizah Arshad, Eng Hooi Tan, Paula Casajust +11 more

Multinational Patterns of Second-line Anti-hyperglycemic Drug Initiation Across Cardiovascular Risk Groups: A Federated Pharmacoepidemiologic Evaluation in LEGEND-T2DM

medRxiv(2022)10.1101/2022.12.27.22283968
Top 65%
0.208DataRank
Top 65%3 citations

Lovedeep Singh Dhingra, Arya Aminorroaya, Kelly Li, Jin Zhou, Faaizah Arshad +42 more

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study

medRxiv(2020)10.1101/2020.06.11.20125849
N/A
0DataRank · unranked
27 citations

Mitchell M. Conover, Seng Chan You, Nicole Pratt, Kristin Kostka, Talita Duarte‐Salles +28 more

Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study

medRxiv(2021)10.1101/2021.03.18.21253778
N/A
0DataRank · unranked
2 citations

Junqing Xie, Kristin Kostka, Talita Duarte‐Salles, Sergio Fernández‐Bertolín, María Aragón +21 more

HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5507
N/A
0DataRank · unranked
105 citations

Anton Pottegård, William H. Crown, Peter Arlett, Darren M. Ashcroft, Eric I. Benchimol +17 more

HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force

Value in Health(2022)10.1016/j.jval.2022.09.001
N/A
0DataRank · unranked
50 citations

Anton Pottegård, William H. Crown, Peter Arlett, Darren M. Ashcroft, Eric I. Benchimol +17 more

Ranitidine Use and Incident Cancer in a Multinational Cohort

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.33495
N/A
0DataRank · unranked
18 citations

Seung In Seo, Thomas Falconer, Chen Yanover, Talita Duarte‐Salles, Sarah Seager +18 more

Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.05.069
N/A
0DataRank · unranked
36 citations

Arya Aminorroaya, Lovedeep Singh Dhingra, Phyllis Thangaraj, Aline Pedroso Camargos, Fan Bu +49 more

Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

medRxiv(2024)10.1101/2024.02.05.24302354
N/A
0DataRank · unranked
4 citations

Arya Aminorroaya, Lovedeep Singh Dhingra, Phyllis Thangaraj, Aline Pedroso Camargos, Fan Bu +49 more

Evaluating the impact of instrumental variables in propensity score models using synthetic and negative control experiments

arXiv (Cornell University)(2024)10.48550/arxiv.2403.14563
N/A
0DataRank · unranked
0 citations

Nicole Pratt, Laura Hester, George Hripcsak, Martijn J. Schuemie, Marc A. Suchard +1 more

Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study

EClinicalMedicine(2025)10.1016/j.eclinm.2025.103096
N/A
0DataRank · unranked
6 citations

Jung Ho Kim, Evan Minty, Jung Ah Lee, Daniel R. Morales, Rohan Khera +22 more

Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DM

medRxiv(2025)10.1101/2025.05.08.25327248
N/A
0DataRank · unranked
2 citations

Fan Bu, Clair Blacketer, Anna Ostropolets, Talita Duarte‐Salles, Benjamin Viernes +29 more

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

The Lancet Digital Health(2020)10.1016/s2589-7500(20)30289-2
N/A
0DataRank · unranked
130 citations

Mitchell M. Conover, Seng Chan You, Nicole Pratt, Kristin Kostka, Talita Duarte‐Salles +28 more

Heterogeneity of Treatment Effects of Glucose-lowering Drug Classes for Type 2 Diabetes: LEGEND-T2DM Network Real-World Evidence

medRxiv(2025)10.1101/2025.06.02.25328066
Top 100%
0DataRank
Top 100%0 citations

Thomas Falconer, Nicole Pratt, Karthik Natarajan, George Hripcsak, David M. Davila-Garcia

Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)

Journal of the American Medical Informatics Association(2020)10.1093/jamia/ocaa103
N/A
0DataRank · unranked
51 citations

Patrick Ryan, Nicole Pratt, Ruijun Chen, Seng Chan You, Harlan M. Krumholz +4 more

Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study

Journal of the American Medical Informatics Association(2020)10.1093/jamia/ocaa124
N/A
0DataRank · unranked
34 citations

Patrick Ryan, Nicole Pratt, Ruijun Chen, Seng Chan You, Harlan M. Krumholz +4 more